Clinical Trials Directory

Trials / Unknown

UnknownNCT05104970

Comparative Pharmacokinetics of Two Different Oral Delivery Systems of Cholecalciferol

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Scotmann Pharmaceuticals · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to adapt the gold standard of research and to explore the comparative bioavailability and clinical efficacy of the two most commonly used forms of Cholecalciferol i.e. ampoules and softgel capsules.

Detailed description

Deficiency of Vitamin D is highly prevalent in all sectors and regions of Pakistan. Its effects encompass multiple pluripotent physiological impacts on human body, including its classical action on bone health and immune modulation. Health care workers are routinely prescribing supplementations to correct the deficiencies. Different forms of Cholecalciferol are available in the market. It ranges from absorba liquids, drops, tablets, softgels to injectable and oral ampoules. Different delivery systems offer different advantages, challenges and efficacies specific to their specific pharmacokinetics. The aim of this study is to adapt the gold standard of research and to explore the comparative bioavailability and clinical efficacy of the two most commonly used forms of Cholecalciferol i.e. ampoules and softgel capsules.

Conditions

Interventions

TypeNameDescription
DRUGSunnyD insta ampouleCholecalciferol 200000 IU insta ampoule
DIETARY_SUPPLEMENTSunnyD STAT softgel capsuleCholecalciferol 200000 IU softgel capsule
DRUGPlacebo SunnyD insta ampouleOlive oil
DIETARY_SUPPLEMENTPlacebo SunnyD STAT softgel capsuleOlive oil

Timeline

Start date
2022-08-09
Primary completion
2023-01-09
Completion
2023-02-10
First posted
2021-11-03
Last updated
2022-05-26

Source: ClinicalTrials.gov record NCT05104970. Inclusion in this directory is not an endorsement.